Lise Kjems - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lise Kjems

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Lipid Research|November 12, 2010

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL functionCatherine E Watson, Nicole Weissbach, Lise Kjems, et al.

The Lancet. Gastroenterology & Hepatology|July 5, 2022

Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trialRichard J Thompson, Henrik Arnell, Reha Artan, et al.

JHEP Reports : Innovation in Hepatology|July 17, 2023

Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasisRichard J Thompson, Reha Artan, Ulrich Baumann, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Lipid Research|November 12, 2010

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL functionCatherine E Watson, Nicole Weissbach, Lise Kjems, et al.

The Lancet. Gastroenterology & Hepatology|July 5, 2022

Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trialRichard J Thompson, Henrik Arnell, Reha Artan, et al.

JHEP Reports : Innovation in Hepatology|July 17, 2023

Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasisRichard J Thompson, Reha Artan, Ulrich Baumann, et al.

Pageof 2